Zabaleta V - Search Results

1

The extradomain a of fibronectin enhances the efficacy of lipopolysaccharide defective Salmonella bacterins as vaccines in mice.

Román BS, Garrido V, Muñoz PM, Arribillaga L, García B, De Andrés X, Zabaleta V, Mansilla C, Farrán I, Lasa I, De Andrés D, Amorena B, Lasarte JJ, Grilló MJ. Román BS, et al. Among authors: zabaleta v. Vet Res. 2012 Apr 19;43(1):31. doi: 10.1186/1297-9716-43-31. Vet Res. 2012. PMID: 22515195 Free PMC article.

2

Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study.

Zabaleta V, Ponchel G, Salman H, Agüeros M, Vauthier C, Irache JM. Zabaleta V, et al. Eur J Pharm Biopharm. 2012 Aug;81(3):514-23. doi: 10.1016/j.ejpb.2012.04.001. Epub 2012 Apr 10. Eur J Pharm Biopharm. 2012. PMID: 22516136 Free article.

3

[Mucopenetrating nanoparticles: vehicles for the oral administration of paclitaxel].

Zabaleta V, Calleja P, Espuelas S, Corrales L, Pío R, Agüeros M, Irache JM. Zabaleta V, et al. Ann Pharm Fr. 2013 Mar;71(2):109-18. doi: 10.1016/j.pharma.2012.12.005. Epub 2013 Feb 27. Ann Pharm Fr. 2013. PMID: 23537412 French.

4

Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles.

Agüeros M, Zabaleta V, Espuelas S, Campanero MA, Irache JM. Agüeros M, et al. Among authors: zabaleta v. J Control Release. 2010 Jul 1;145(1):2-8. doi: 10.1016/j.jconrel.2010.03.012. Epub 2010 Mar 27. J Control Release. 2010. PMID: 20347897

5

An HPLC with evaporative light scattering detection method for the quantification of PEGs and Gantrez in PEGylated nanoparticles.

Zabaleta V, Campanero MA, Irache JM. Zabaleta V, et al. J Pharm Biomed Anal. 2007 Sep 3;44(5):1072-8. doi: 10.1016/j.jpba.2007.05.006. Epub 2007 May 22. J Pharm Biomed Anal. 2007. PMID: 17587532

6

Influence of dextran on the bioadhesive properties of poly(anhydride) nanoparticles.

Porfire AS, Zabaleta V, Gamazo C, Leucuta SE, Irache JM. Porfire AS, et al. Among authors: zabaleta v. Int J Pharm. 2010 May 5;390(1):37-44. doi: 10.1016/j.ijpharm.2009.08.017. Epub 2009 Aug 25. Int J Pharm. 2010. PMID: 19712734

7

In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration.

Inchaurraga L, Martín-Arbella N, Zabaleta V, Quincoces G, Peñuelas I, Irache JM. Inchaurraga L, et al. Among authors: zabaleta v. Eur J Pharm Biopharm. 2015 Nov;97(Pt A):280-9. doi: 10.1016/j.ejpb.2014.12.021. Epub 2014 Dec 23. Eur J Pharm Biopharm. 2015. PMID: 25541441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters